iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership35,873 shares
Latest Disclosed Value $ 6,057,156
IFP Advisors, Inc ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 35,873 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $6,057,156 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 20,486 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 75.11% during the quarter. The current value of the position is $4,701,157 USD.

IFP Advisors, Inc has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ISHARES TR cs 464287556 35,873 15,387 75.11 6,057 75.21 0.1256
2026-02-06 2025-12-31 13F ISHARES TR cs 464287556 20,486 1,424 7.47 3,457 25.66 0.0776
2026-02-06 2025-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH cs 464287556 19,062 -783 -3.95 2,752 9.60 0.0715
2025-12-02 2025-09-30 13F ISHARES TR ISHARES BIOTECH cs 464287556 19,066 -779 2,753 0.0710
2025-07-24 2025-06-30 13F I cs 464287556 19,845 -4 -0.02 2,511 -1.10 0.0714
2025-05-05 2025-03-31 13F ISHARES TR cs 464287556 19,849 3,831 23.92 2,539 19.89 0.0783
2025-02-04 2024-12-31 13F ISHARES TR cs 464287556 16,018 11,266 237.08 2,118 206.37 0.0694
2025-02-04 2024-09-30 13F ISHARES TR cs 464287556 4,752 -93 -1.92 692 3.91 0.0249
2024-07-30 2024-06-30 13F ISHARES TR cs 464287556 4,845 -293 -5.70 665 -5.67 0.0264
2024-07-30 2024-03-31 13F ISHARES TR cs 464287556 5,138 -447 -8.00 705 -6.99 0.0309
2024-01-09 2023-12-31 13F ISHARES TR cs 464287556 5,585 -597 -9.66 759 0.26 0.0358
2023-10-12 2023-09-30 13F ISHARES TR cs 464287556 6,182 -562 -8.33 756 -11.68 0.0340
2023-08-14 2023-06-30 13F/A-1 ISHARES TR cs 464287556 6,744 -1,825 -21.30 856 -9.03 0.0358
2023-08-04 2023-06-30 13F ISHARES TR cs 464287556 6,744 -1,825 741 0.0343
2023-04-18 2023-03-31 13F ISHARES TR cs 464287556 8,569 -2,827 -24.81 941 94,000.00 0.0410
2023-02-07 2022-12-31 13F ISHARES TR cs 464287556 11,396 -665 -5.51 1 -99.92 0.0335
2022-11-08 2022-09-30 13F ISHARES TR cs 464287556 12,061 292 2.48 1,327 2.31 0.0346
2022-09-06 2022-06-30 13F/A-1 ISHARES TR cs 464287556 11,769 0 0.00 1,297 0.00 0.0416
2022-08-12 2022-06-30 13F ISHARES TR ISHARES BIOTECH Stock 464287556 1,242 -10,527 136 0.2435
2022-09-06 2022-03-31 13F/A-1 ISHARES TR cs 464287556 11,769 1,298 12.40 1,297 -18.84 0.0416
2022-08-08 2022-03-31 13F ISHARES TR ISHARES BIOTECH Stock 464287556 11,848 1,377 1,298 0.0265
2022-01-12 2021-12-31 13F ISHARES TR ISHARES BIOTECH Stock 464287556 10,471 1,525 17.05 1,598 10.66 0.0312
2021-10-06 2021-09-30 13F ISHARES TR ISHARES BIOTECH Stock 464287556 8,946 -584 -6.13 1,444 -7.14 0.0289
2021-07-13 2021-06-30 13F ISHARES TR ISHARES BIOTECH Stock 464287556 9,530 -811 -7.84 1,555 0.00 0.0322
2021-04-30 2021-03-31 13F ISHARES TR NASDAQ BIOTECH Stock 464287556 10,341 -1,081 -9.46 1,555 -9.80 0.0303
2021-01-25 2020-12-31 13F ISHARES TR NASDAQ BIOTECH Stock 464287556 11,422 4,225 58.71 1,724 77.55 0.0699
2020-10-29 2020-09-30 13F ISHARES TR NASDAQ BIOTECH Stock 464287556 7,197 1,760 32.37 971 32.83 0.0580
2020-08-05 2020-06-30 13F ISHARES TR NASDAQ BIOTECH Stock 464287556 5,437 1,952 56.01 731 99.18 0.0579
2020-05-12 2020-03-31 13F ISHARES TR NASDAQ BIOTECH Stock 464287556 3,485 -3,822 -52.31 367 -58.62 0.0370
2020-01-17 2019-12-31 13F ISHARES TR NASDAQ BIOTECH Stock 464287556 7,307 -139 -1.87 887 20.68 0.0667
2019-11-07 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Stock 464287556 7,446 -15,242 -67.18 735 -70.99 0.0492
2019-05-15 2019-03-31 13F ISHARES NASDAQBIOTECHNOLOGY ETF ETF 464287556 22,688 -32,002 -58.52 2,534 -51.15 0.3460
2019-06-03 2018-12-31 13F/A-10 ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 54,690 -48,319 -46.91 5,187 -58.71 0.3162
2019-01-23 2018-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 54,690 -48,319 5,187 0.3162
2019-06-03 2018-09-30 13F/A-9 ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 103,009 5,801 5.97 12,561 17.67 0.5120
2018-10-25 2018-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 103,009 5,801 12,561 0.5120
2019-06-03 2018-06-30 13F/A-8 ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 97,208 -27,953 -22.33 10,675 -20.44 0.4489
2018-08-07 2018-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 97,208 -28,730 10,675
2019-06-03 2018-03-31 13F/A-7 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 125,161 600 0.48 13,417 0.48 0.6082
2018-05-09 2018-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 125,938 1,377 13,443
2019-06-03 2017-12-31 13F/A-6 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 124,561 98,870 384.84 13,353 55.81 0.6053
2018-01-24 2017-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 124,561 98,870 13,353
2017-10-30 2017-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 25,691 1,713 7.14 8,570 15.27 0.3403
2019-06-03 2017-06-30 13F/A-5 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 23,978 -815 -3.29 7,435 2.26 0.3152
2017-07-31 2017-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 23,978 -815 7,435
2019-06-03 2017-03-31 13F/A-4 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 24,793 3,227 14.96 7,271 27.05 0.3167
2017-04-26 2017-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 24,793 3,227 7,271
2019-06-03 2016-12-31 13F/A-3 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 21,566 10,458 94.15 5,723 78.01 0.2762
2017-02-14 2016-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 21,566 10,458 5,723
2016-11-04 2016-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 11,108 -1,474 -11.72 3,215 -0.71 0.1672
2019-06-03 2016-06-30 13F/A-2 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 12,582 -10,106 -44.54 3,238 27.78 0.1808
2016-08-22 2016-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 12,582 -10,106 3,238
2019-06-03 2016-03-31 13F/A-1 ISHARES NASDAQBIOTECHNOLOGY ETF ETF 464287556 22,688 3,117 15.93 2,534 -61.73 0.3460
2016-05-02 2016-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 9,662 -9,909 2,520
2016-02-11 2015-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 19,571 19,571 6,621 0.4444
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-06-03 2018-03-31 13F/A ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-06-03 2017-12-31 13F/A ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF Call 600 64 n/a n/a n/a
2018-01-24 2017-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF Call 600 64 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.